東方中科(002819.SZ)2021年度淨利潤預增58.89%-104.29%(重組後)
格隆匯1月29日丨東方中科(002819.SZ)公佈,預計2021年度歸屬於上市公司股東的淨利潤1.4億元-1.8億元,同比增長58.89%-104.29%(重組後);扣除非經常性損益後的淨利潤1.3億元-1.7億元,同比增長47.04%-92.28%(重組後)。業績變動原因如下:
(一)報吿期內,公司測試測量業務持續增長。
(二)2021年11月24日公司重大資產重組定向增發新股登記上市,2021年12月北京萬里紅科技有限公司(“萬里紅”)納入公司合併報表範圍。重大資產重組完成後,萬里紅資產注入,公司經營規模和盈利能力得到顯著提高,從而帶來業績大幅增長。
(三)報吿期內,公司完成重大資產重組項目,併購相關費用對歸屬於上市公司股東淨利潤的影響金額約為955萬元。
(四)公司報吿期內股份支付費用預計金額為1219萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.